Intuitive Surgical's da Vinci system is operated entirely by a surgeon seated at a console in the operating room, not by an autonomous machine. As of December 31, 2024, 9,902 systems were installed worldwide and surgeons completed roughly 2,683,000 procedures on the platform that year, even as a single da Vinci Xi unit still costs about $1.5 million. In March 2024, Intuitive added Force Feedback to its fifth-generation da Vinci 5 system.
How Does the da Vinci Robotic System Work, and How Do Surgeons Control It From the Console?
A surgeon operates da Vinci entirely from a console in the operating room, directly commanding the camera and every instrument. Intuitive Surgical describes the setup plainly: "Your surgeon is in the operating room with you, seated at a console. From the console, your surgeon is in full control of the camera and instruments" CITE:E1. The U.S. FDA underlines that this control is not optional or partial — the agency notes the device "is not actually a robot because it cannot perform surgery without direct human control," placing da Vinci outside the category of autonomous machines CITE:E2. The FDA formally classifies da Vinci and similar platforms as Robotically-Assisted Surgical (RAS) devices, defined as systems that let a surgeon "use computer and software technology to control and move surgical instruments through one or more tiny incisions in the patient's body (minimally invasive) for a variety of surgical procedures" CITE:E4.
What Clinical Benefits Does da Vinci Provide for Minimally Invasive and Complex Procedures?
The FDA attributes two specific benefits to RAS devices like da Vinci: enabling minimally invasive surgery and assisting with complex tasks in confined areas of the body. In its own words, "the benefits of a RAS device may include its ability to facilitate minimally invasive surgery and assist with complex tasks in confined areas of the body" CITE:E5. Both benefits still route through the surgeon at the console rather than through independent machine action, consistent with the operating principle described above.
How Widely Is da Vinci Used Worldwide, and What Do the Numbers Show?
Intuitive Surgical reported an installed base of 9,902 da Vinci systems worldwide as of December 31, 2024, with surgeons completing an estimated 2,683,000 procedures on the platform during that year CITE:E3. The regional breakdown, disclosed in the company's Form 10-K for fiscal year 2024, shows where those systems are concentrated:
| Region | Installed da Vinci systems (as of Dec 31, 2024) |
|---|
| United States | 5,807 |
| Europe | 1,867 |
| Asia | 1,745 |
| Rest of world | 483 |
| Global total | 9,902 |
Globally, surgeons using the technology completed approximately 2,683,000 surgical procedures of various types in hospitals during the year ended December 31, 2024 CITE:E3.
What Cost and Economic Barriers Limit da Vinci Adoption?
A single da Vinci Xi system still costs approximately $1.5 million, a price that a peer-reviewed review in the National Institutes of Health's PMC database identifies as a common obstacle to adopting this kind of surgical innovation CITE:E6. The review states plainly: "the significant cost of the system, as the Xi still costs approximately $1.5 million per system" remains a barrier CITE:E6. That figure sits alongside the scale reported by Intuitive Surgical itself — a global installed base of 9,902 systems and 2,683,000 procedures in 2024 CITE:E3 — showing that per-unit cost and platform-wide adoption are two separate variables in the same picture.
What Does the Latest da Vinci 5 Update With Force Feedback Mean?
Intuitive Surgical secured FDA 510(k) clearance for its fifth-generation da Vinci 5 multiport system on March 14, 2024, adding Force Feedback technology for the first time CITE:E7. The clearance announcement states that "da Vinci 5 introduces Force Feedback technology and optional instruments that enable the system to measure and surgeons to feel subtle forces exerted on tissue during surgery" CITE:E7. The new capability changes what the surgeon can sense at the console, not who is doing the controlling: the system still measures force so the surgeon can feel it, and the surgeon still directs every instrument movement, consistent with the FDA's classification of da Vinci as a human-controlled RAS device CITE:E2 CITE:E4.
What This Means
Taken together, the evidence describes a platform that has scaled to 9,902 installed systems and roughly 2,683,000 annual procedures worldwide CITE:E3 while remaining, by the FDA's own classification, dependent on direct human control at every step CITE:E2 CITE:E4. The March 2024 addition of Force Feedback to da Vinci 5 extends what a surgeon can perceive through the console rather than reducing the surgeon's role CITE:E7, and it arrives alongside — not in place of — the $1.5 million per-unit cost that the PMC review identifies as a continuing barrier to adoption CITE:E6.